---
figid: PMC2744278__zlj9990988150004
figlink: /pmc/articles/PMC2744278/figure/F4/
number: Fig 4
caption: Signal transducer and activator of transcription (STAT) targeting strategies.
  (A) Cytokine receptor antagonists or receptor-directed monoclonal antibodies. Blocking
  activation of growth factor/cytokine receptors with monoclonal antibodies might
  be beneficial., (B) Tyrosine kinase inhibitors. Inhibition of upstream tyrosine
  kinases, such as Janus family tyrosine kinase (JAK), breakpoint cluster region-abelson
  tyrosine kinase, FMS-related tyrosine kinase 3, and sarcoma (Schmidt-Ruppin A-2)
  viral oncogene homolog (avian), with resultant downregulation of STATs has proven
  to be the most effective STAT-targeting strategy.,,,,,,,– (C) Phosphotyrosine phosphatases,,,
  (D) suppressors of cytokine signaling proteins,, and (E) protein inhibitors of activated
  STATs, are negative regulators of STAT activity. Activating these molecules represents
  another promising therapeutic approach., (F) Peptidomimetic inhibitors of STAT dimerization
  directly and selectively target STATs., (G) Targeting STAT nucleocytoplasmic shuttling.
  (H) Antisense oligodeoxynucleotides and small interfering RNA molecules cause selective
  STAT mRNA inhibition.– (I) Disruption of STAT-DNA binding by G-quartets and decoy
  oligonucleotides.,, (J) Dominant-negative STAT_isoforms inhibit STAT signaling pathway
  and tumor growth.,,,, (K) Arsenic trioxide indirectly decreases STAT activation
  by direct protein tyrosine kinase (PTK) inhibition.,– (L) Novel platinum (IV) compounds
  directly bind to STAT molecule and block DNA-binding activity., P, phosphorus; Onco-PTK,
  oncogenic PTK.
pmcid: PMC2744278
papertitle: Targeting Signal Transducer and Activator of Transcription Signaling Pathway
  in Leukemias.
reftext: Mustafa Benekli, et al. J Clin Oncol. 2009 Sep 10;27(26):4422-4432.
pmc_ranked_result_index: '145754'
pathway_score: 0.9436758
filename: zlj9990988150004.jpg
figtitle: Signal transducer and activator of transcription (STAT) targeting strategies
year: '2009'
organisms: Homo sapiens
ndex: 0fff2f16-deff-11ea-99da-0ac135e8bacf
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC2744278__zlj9990988150004.html
  '@type': Dataset
  description: Signal transducer and activator of transcription (STAT) targeting strategies.
    (A) Cytokine receptor antagonists or receptor-directed monoclonal antibodies.
    Blocking activation of growth factor/cytokine receptors with monoclonal antibodies
    might be beneficial., (B) Tyrosine kinase inhibitors. Inhibition of upstream tyrosine
    kinases, such as Janus family tyrosine kinase (JAK), breakpoint cluster region-abelson
    tyrosine kinase, FMS-related tyrosine kinase 3, and sarcoma (Schmidt-Ruppin A-2)
    viral oncogene homolog (avian), with resultant downregulation of STATs has proven
    to be the most effective STAT-targeting strategy.,,,,,,,– (C) Phosphotyrosine
    phosphatases,,, (D) suppressors of cytokine signaling proteins,, and (E) protein
    inhibitors of activated STATs, are negative regulators of STAT activity. Activating
    these molecules represents another promising therapeutic approach., (F) Peptidomimetic
    inhibitors of STAT dimerization directly and selectively target STATs., (G) Targeting
    STAT nucleocytoplasmic shuttling. (H) Antisense oligodeoxynucleotides and small
    interfering RNA molecules cause selective STAT mRNA inhibition.– (I) Disruption
    of STAT-DNA binding by G-quartets and decoy oligonucleotides.,, (J) Dominant-negative
    STAT_isoforms inhibit STAT signaling pathway and tumor growth.,,,, (K) Arsenic
    trioxide indirectly decreases STAT activation by direct protein tyrosine kinase
    (PTK) inhibition.,– (L) Novel platinum (IV) compounds directly bind to STAT molecule
    and block DNA-binding activity., P, phosphorus; Onco-PTK, oncogenic PTK.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - JAK2
  - STAT6
  - JAK3
  - JAK1
  - STAT4
  - STAT5B
  - STAT3
  - STAT5A
  - STAT1
  - STAT2
  - TYK2
genes:
- word: JAK
  symbol: JAK
  source: bioentities_symbol
  hgnc_symbol: JAK2
  entrez: '3717'
- word: STAT
  symbol: STAT
  source: bioentities_symbol
  hgnc_symbol: STAT6
  entrez: '6778'
- word: JAK
  symbol: JAK
  source: bioentities_symbol
  hgnc_symbol: JAK3
  entrez: '3718'
- word: JAK
  symbol: JAK
  source: bioentities_symbol
  hgnc_symbol: JAK1
  entrez: '3716'
- word: STAT
  symbol: STAT
  source: bioentities_symbol
  hgnc_symbol: STAT4
  entrez: '6775'
- word: STAT
  symbol: STAT
  source: bioentities_symbol
  hgnc_symbol: STAT5B
  entrez: '6777'
- word: STAT
  symbol: STAT
  source: bioentities_symbol
  hgnc_symbol: STAT3
  entrez: '6774'
- word: STAT
  symbol: STAT
  source: bioentities_symbol
  hgnc_symbol: STAT5A
  entrez: '6776'
- word: STAT
  symbol: STAT
  source: bioentities_symbol
  hgnc_symbol: STAT1
  entrez: '6772'
- word: STAT
  symbol: STAT
  source: bioentities_symbol
  hgnc_symbol: STAT2
  entrez: '6773'
- word: JAK
  symbol: JAK
  source: bioentities_symbol
  hgnc_symbol: TYK2
  entrez: '7297'
chemicals: []
diseases: []
---
